Detalhe da pesquisa
1.
Mathematical modelling for antibiotic resistance control policy: do we know enough?
BMC Infect Dis
; 19(1): 1011, 2019 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31783803
2.
Measuring the impact of Ebola control measures in Sierra Leone.
Proc Natl Acad Sci U S A
; 112(46): 14366-71, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460023
3.
The WHO costing and budgeting tool for national action plans on antimicrobial resistance-a practical addition to the WHOle toolkit.
JAC Antimicrob Resist
; 5(3): dlad064, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251302
4.
Do you see the problem? Visualising a generalised 'complex local system' of antibiotic prescribing across the United Kingdom using qualitative interview data.
Crit Public Health
; 33(4): 459-471, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013783
5.
The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses.
Syst Rev
; 12(1): 165, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710334
6.
Sankey diagrams can clarify 'evidence attrition': A systematic review and meta-analysis of the effectiveness of rapid diagnostic tests for antimicrobial resistance.
J Clin Epidemiol
; 144: 173-184, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843860
7.
NIMble innovation-a networked model for public antibiotic trials.
Lancet Microbe
; 2(11): e637-e644, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544083
8.
Quality and Utility of Information Captured by Surveillance Systems Relevant to Antimicrobial Resistance (AMR): A Systematic Review.
Antibiotics (Basel)
; 10(4)2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924412
9.
Antimicrobial resistance and COVID-19: Intersections and implications.
Elife
; 102021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588991
10.
A framework for identifying and mitigating the equity harms of COVID-19 policy interventions.
J Clin Epidemiol
; 128: 35-48, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526461
11.
The antibiotic subscription model: fostering innovation or repackaging old drugs?
Lancet Microbe
; 4(1): e2-e3, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154717
12.
Why is the UK subscription model for antibiotics considered successful?
Lancet Microbe
; 4(11): e852-e853, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625429
13.
Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward.
Diagn Microbiol Infect Dis
; 91(4): 331-335, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706478
14.
Sale of UK's Vaccine Manufacturing and Innovation Centre.
BMJ
; 376: e069999, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197301
15.
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END).
J Clin Epidemiol
; 151: 88-95, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868494
16.
Antimicrobial resistance at the G7.
BMJ
; 373: n1417, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083377
17.
Vaccinating against covid-19 in people who report allergies.
BMJ
; 372: n120, 2021 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461962
18.
Antibiotic resistance: don't blame patients.
BMJ
; 364: l1218, 2019 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890532
19.
Subscription model for antibiotic development.
BMJ
; 366: l5364, 2019 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492658